771 related articles for article (PubMed ID: 16139257)
1. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
Srinivasan S; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
[TBL] [Abstract][Full Text] [Related]
2. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
Govindaraj A; Selvam R
BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
[TBL] [Abstract][Full Text] [Related]
3. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
Atmani F; Lacour B; Daudon M
Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
[TBL] [Abstract][Full Text] [Related]
4. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
Kalaiselvi P; Udayapriya KL; Selvam R
BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
[TBL] [Abstract][Full Text] [Related]
5. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
Asokan D; Kalaiselvi P; Varalakshmi P
Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
[TBL] [Abstract][Full Text] [Related]
7. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight urinary proteins and renal lithiasis.
Resnick MI; Boyce WH
Invest Urol; 1979 Jan; 16(4):270-3. PubMed ID: 429118
[TBL] [Abstract][Full Text] [Related]
9. [The influence of uric acid on the calcium oxalate stone formation (author's transl)].
Matouschek E; Huber R
Urologe A; 1979 Jul; 18(4):211-4. PubMed ID: 38552
[TBL] [Abstract][Full Text] [Related]
10. Nuclear pore complex oxalate binding protein p62: expression in different kidney disorders.
Sivakamasundari P; Kalaiselvi P; Sakthivel R; Selvam R; Varalakshmi P
Clin Chim Acta; 2004 Sep; 347(1-2):111-9. PubMed ID: 15313148
[TBL] [Abstract][Full Text] [Related]
11. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
[TBL] [Abstract][Full Text] [Related]
12. Role of a protein inhibitor isolated from human renal stone matrix in urolithiasis.
Aggarwal S; Tandon C; Forouzandeh M; Singla SK; Kiran R; Jethi RK
Indian J Biochem Biophys; 2005 Apr; 42(2):113-7. PubMed ID: 23923571
[TBL] [Abstract][Full Text] [Related]
13. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
Ryall RL; Chauvet MC; Grover PK
BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
[TBL] [Abstract][Full Text] [Related]
14. Concentration of a potent calcium oxalate monohydrate crystal growth inhibitor in the urine of normal persons and kidney stone patients by ELISA-based assay system employing monoclonal antibodies.
Moghadam MF; Tandon C; Aggarwal S; Singla SK; Singh SK; Sharma SK; Varshney GC; Jethi RK
J Cell Biochem; 2003 Dec; 90(6):1261-75. PubMed ID: 14635198
[TBL] [Abstract][Full Text] [Related]
15. A cationic protein from a urate-calcium oxalate stone: isolation and purification of a shared protein.
Binette JP; Binette MB
Scanning Microsc; 1993 Sep; 7(3):1107-10. PubMed ID: 7511834
[TBL] [Abstract][Full Text] [Related]
16. Crystallization properties in urine from calcium oxalate stone formers.
Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
[TBL] [Abstract][Full Text] [Related]
17. Calprotectin-like protein is related to soluble organic matrix in calcium oxalate urinary stone.
Umekawa T; Kurita T
Biochem Mol Biol Int; 1994 Sep; 34(2):309-13. PubMed ID: 7849642
[TBL] [Abstract][Full Text] [Related]
18. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization.
Atmani F; Mizon J; Khan SR
Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621
[TBL] [Abstract][Full Text] [Related]
19. The hyperuricosuric calcium oxalate stone former.
Sarig S
Miner Electrolyte Metab; 1987; 13(4):251-6. PubMed ID: 3306317
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
Favus MJ; Coe FL
Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
